Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 May;6(3):189-97.
doi: 10.1016/j.apsb.2016.03.009. Epub 2016 Apr 22.

Parishin C's prevention of Aβ 1-42-induced inhibition of long-term potentiation is related to NMDA receptors

Affiliations

Parishin C's prevention of Aβ 1-42-induced inhibition of long-term potentiation is related to NMDA receptors

Zhihui Liu et al. Acta Pharm Sin B. 2016 May.

Abstract

The rhizome of Gastrodia elata (GE), a herb medicine, has been used for treatment of neuronal disorders in Eastern Asia for hundreds of years. Parishin C is a major ingredient of GE. In this study, the i.c.v. injection of soluble Aβ 1-42 oligomers model of LTP injury was used. We investigated the effects of parishin C on the improvement of LTP in soluble Aβ 1-42 oligomer-injected rats and the underlying electrophysiological mechanisms. Parishin C (i.p. or i.c.v.) significantly ameliorated LTP impairment induced by i.c.v. injection of soluble Aβ 1-42 oligomers. In cultured hippocampal neurons, soluble Aβ 1-42 oligomers significantly inhibited NMDAR currents while not affecting AMPAR currents and voltage-dependent currents. Pretreatment with parishin C protected NMDA receptor currents from the damage induced by Aβ. In summary, parishin C improved LTP deficits induced by soluble Aβ 1-42 oligomers. The protection by parishin C against Aβ-induced LTP damage might be related to NMDA receptors.

Keywords: Ion channels; Long-term potentiation; NMDA receptors; Neuroprotection; Parishin C.

PubMed Disclaimer

Figures

fx1
Graphical abstract
Fig. 1
Figure 1
Chemical structures of gastrodin and parishin C.
Fig. 2
Figure 2
Memantine rescued inhibition of LTP induced by soluble Aβ1–42 oligomers in rats. (A) and (B) showed original traces of PS before (1) and after (2) HFS. (C) 5 mg/kg MK-801 abolished HFS induced LTP (control group n=4; MK-801 group n=5). (D) 2 μmol/L soluble Aβ1–42 oligomers significantly inhibited LTP (vs. control group, P< 0.05), and 10 mg/kg memantine administrated i.p. in advance rescued this inhibition (control group n=7, Aβ1–42 group n=5, memantine group n=5). Data were shown as mean ± SEM, P<0.05 vs. control group, #P< 0.05 vs. Aβ1–42 group.
Fig. 3
Figure 3
Effects of parishin C on inhibition of LTP induced by soluble Aβ1–42 oligomers in rats. (A) showed original traces of PS before (1) and after (2) HFS in four groups. (B) Parishin C 20 mg/kg was given i.p. for two days before LTP recordings and was given i.p. 10 min before i.c.v. injection of 2 μmol/L soluble Aβ1–42 oligomers. (C) Parishin C 10 μmol/L was given i.c.v. before 2 μmol/L soluble Aβ1–42 oligomers injection. HFS was performed 60 min after injection of soluble Aβ1–42 oligomers in all experiments. Parishin C improved LTP induction significantly after Aβ treatment (P < 0.05). Data were shown as mean ± SEM, control group n=7, Aβ1–42 group n=5, pC (i.p.) group n=5, pC (i.c.v.) group n=5, P < 0.05 vs. control group, #P<0.05 vs. Aβ1–42 group.
Fig. 4
Figure 4
Parishin C had no effects on normal LTP and ion channels. (A) Upper traces of PS before (1) and after (2) HFS in two groups. Parishin C 20 mg/kg given i.p. 30 min before HFS did not influence the baseline and LTP induction in normal rats (control group n=8, pC group n=7). (B) Perfusion of 10 μmol/L parishin C for 10 min had no effects on AMPAR currents in primary cultured hippocampal pyramidal neurons. The bars above current recordings show pressure injection of 1 s, 3 μmol/L AMPA (n=3). (C) Perfusion of 10 μmol/L parishin C for 10 min had no effects on NMDAR currents in primary cultured hippocampal pyramidal neurons. The bars above current recordings show pressure injection of 1 s, 100 μmol/L NMDA and 10 μmol/L glycine (n=5). Data were shown in mean±SEM. The amplitudes of all currents were normalized to the first evoked at –70 mV.
Fig. 5
Figure 5
10 μmol/L parishin C had no effects on voltage-dependent currents in cultured hippocampal neurons of rats. (A) parishin C (10 μmol/L) had no effects on voltage-dependent total sodium currents (n = 5), holding potential =–80 mV. (B) parishin C (10 μmol/L) had no effects on voltage-dependent total outward potassium currents (n = 3), holding potential = –70 mV. (C) parishin C (10 μmol/L) had no effects on voltage-dependent total calcium currents (n = 3), holding potential =–90 mV. Data are shown in mean ± SEM.
Fig. 6
Figure 6
Parishin C protected against inhibition of NMDAR currents by 2 μmol/L soluble Aβ1–42 oligomers but not AMPAR currents in primary cultured hippocampal neurons. Holding potential was –70 mV and external solution was with 0.1 μmol/L TTX, and without Mg2+. (A) Bath perfusion of 2 μmol/L soluble Aβ1–42 oligomers for 10 min had no effects on AMPAR currents. Short bar means pressure injection of 3 μmol/L AMPA. (B) Bath perfusion of 2 μmol/L soluble Aβ1–42 oligomers for 10 min inhibited NMDAR currents, and the inhibition continued during wash. Parishin C (10 μmol/L) perfusion 10 min beforehand prevented Aβ’s inhibitory effects. Short bar meant pressure injection of 100 μmol/L NMDA and 10 μmol/L glycine. (C) The AMPAR currents were not changed during soluble Aβ1–42 oligomers perfusion (n=3). (D) Soluble Aβ1–42 oligomers significantly inhibited NMDAR currents but it was rescued by perfusion of parishin C (Aβ1–42 group n=5, pC+ Aβ1–42 group n=6). P<0.05 vs. currents before perfusion, #P<0.05 vs. Aβ1–42 group. Data are mean±SEM. The amplitudes of all currents were normalized to the first evoked at –70 mV.

Similar articles

Cited by

References

    1. Huang G.B., Zhao T., Muna S.S., Jin H.M., Park J.I., Jo K.S. Therapeutic potential of Gastrodia elata Blume for the treatment of Alzheimer׳s disease. Neural Regen Res. 2013;8:1061–1070. - PMC - PubMed
    1. Zhu A.H., Tian J.Z., Zhong J., Yang C.Z., Shi J., Yin J.X. A clinical study on a randomized, double-blind control of Chinese medicine granules in treatment of vascular dementi. China J Chin Mater Med. 2006;31:1722–1725. - PubMed
    1. Xu WJ, Tan XC, Zhang M, Zhao LM, Liu Y, Shi JG, et al., inventor; Beijing Kelaibo Pharmaceutical Development, assignee. Gastrodia elata plant extract for preventing senile dementia and its preparing method. China Patent CN200510128785. 2007 June 13
    1. Wang K, Shi JG, Zhao LM, Zhao DL, Zou DC, Zhang M, et al., inventor; Beijing Collab Pharma Co. Ltd., assignee. Application of Gastrodiaelata blume parishin extractive in preparation of medicament for protecting brain. China Patent CN102727506A. 2012 October 17
    1. Wang K, Shi JG, Liu Y, Zhao LM, Zhang M, Chen MX, inventor; Beijing Collab Pharma Co. Ltd., assignee. Gastrodiaelata blume plant extract for preventing and treating vascular dementia and preparation method thereof. China Patent CN101628086A 2010 January 20

LinkOut - more resources